Standard

Trace amine associated receptor 1 and movement control. / Sotnikova, Tatyana D.; Zorina, Olesya I.; Ghisi, Valentina; Caron, Marc G.; Gainetdinov, Raul R.

In: Parkinsonism and Related Disorders, Vol. 14, No. SUPPL.2, 01.07.2008.

Research output: Contribution to journal › Article › peer-review

Harvard

Sotnikova, TD, Zorina, OI, Ghisi, V, Caron, MG & Gainetdinov, RR 2008, 'Trace amine associated receptor 1 and movement control', Parkinsonism and Related Disorders, vol. 14, no. SUPPL.2. https://doi.org/10.1016/j.parkreldis.2008.04.006

APA

Sotnikova, T. D., Zorina, O. I., Ghisi, V., Caron, M. G., & Gainetdinov, R. R. (2008). Trace amine associated receptor 1 and movement control. Parkinsonism and Related Disorders, 14(SUPPL.2). https://doi.org/10.1016/j.parkreldis.2008.04.006

Vancouver

Sotnikova TD, Zorina OI, Ghisi V, Caron MG, Gainetdinov RR. Trace amine associated receptor 1 and movement control. Parkinsonism and Related Disorders. 2008 Jul 1;14(SUPPL.2). https://doi.org/10.1016/j.parkreldis.2008.04.006

Author

Sotnikova, Tatyana D. ; Zorina, Olesya I. ; Ghisi, Valentina ; Caron, Marc G. ; Gainetdinov, Raul R. / Trace amine associated receptor 1 and movement control. In: Parkinsonism and Related Disorders. 2008 ; Vol. 14, No. SUPPL.2.

BibTeX

@article{a64d8b158fda460ea754add3961e7a76,
title = "Trace amine associated receptor 1 and movement control",
abstract = "The recently discovered trace amine associated receptors (TAARs) represent attractive potential mediators of certain aspects of movement control. The TAAR that is best characterized, TAAR1, is particularly interesting because it can be activated by a variety of monoaminergic compounds including trace amines, amphetamines and dopamine metabolites. By using an experimental paradigm developed in our laboratory that involves a novel model of acute dopamine deficiency (DDD mice), and mice lacking TAAR1 (TAAR1 knockout mice), we explored the role of TAAR1 in movement control and actions of antiparkinsonian drugs. These investigations may eventually bring novel approaches to the pharmacology of Parkinson's disease.",
keywords = "Amphetamine, Dopamine, L-dopa, TAAR1, Trace amine",
author = "Sotnikova, {Tatyana D.} and Zorina, {Olesya I.} and Valentina Ghisi and Caron, {Marc G.} and Gainetdinov, {Raul R.}",
year = "2008",
month = jul,
day = "1",
doi = "10.1016/j.parkreldis.2008.04.006",
language = "English",
volume = "14",
journal = "Parkinsonism and Related Disorders",
issn = "1353-8020",
publisher = "Elsevier",
number = "SUPPL.2",

}

RIS

TY - JOUR

T1 - Trace amine associated receptor 1 and movement control

AU - Sotnikova, Tatyana D.

AU - Zorina, Olesya I.

AU - Ghisi, Valentina

AU - Caron, Marc G.

AU - Gainetdinov, Raul R.

PY - 2008/7/1

Y1 - 2008/7/1

N2 - The recently discovered trace amine associated receptors (TAARs) represent attractive potential mediators of certain aspects of movement control. The TAAR that is best characterized, TAAR1, is particularly interesting because it can be activated by a variety of monoaminergic compounds including trace amines, amphetamines and dopamine metabolites. By using an experimental paradigm developed in our laboratory that involves a novel model of acute dopamine deficiency (DDD mice), and mice lacking TAAR1 (TAAR1 knockout mice), we explored the role of TAAR1 in movement control and actions of antiparkinsonian drugs. These investigations may eventually bring novel approaches to the pharmacology of Parkinson's disease.

AB - The recently discovered trace amine associated receptors (TAARs) represent attractive potential mediators of certain aspects of movement control. The TAAR that is best characterized, TAAR1, is particularly interesting because it can be activated by a variety of monoaminergic compounds including trace amines, amphetamines and dopamine metabolites. By using an experimental paradigm developed in our laboratory that involves a novel model of acute dopamine deficiency (DDD mice), and mice lacking TAAR1 (TAAR1 knockout mice), we explored the role of TAAR1 in movement control and actions of antiparkinsonian drugs. These investigations may eventually bring novel approaches to the pharmacology of Parkinson's disease.

KW - Amphetamine

KW - Dopamine

KW - L-dopa

KW - TAAR1

KW - Trace amine

UR - http://www.scopus.com/inward/record.url?scp=47049100558&partnerID=8YFLogxK

U2 - 10.1016/j.parkreldis.2008.04.006

DO - 10.1016/j.parkreldis.2008.04.006

M3 - Article

C2 - 18585080

AN - SCOPUS:47049100558

VL - 14

JO - Parkinsonism and Related Disorders

JF - Parkinsonism and Related Disorders

SN - 1353-8020

IS - SUPPL.2

ER -

ID: 36305833